| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5942600 | Atherosclerosis | 2016 | 34 Pages |
Abstract
Mineralocorticoid antagonism provides vasculoprotective effects and should be clinically evaluated for vascular disease such as erectile dysfunction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mario T. Kratz, Stephan H. Schirmer, Magnus Baumhäkel, Michael Böhm,